Protalix BioTherapeutics (PLX) Tax Rate Growth (1y) (2024 - 2026)

Protalix BioTherapeutics (PLX) Tax Rate Growth (1y) (2024 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,725.60 Bn 68,725.31 Bn -
2 Nanobiotix 1,953.19 Bn 1,953.13 Bn -
3 Akari Therapeutics 1,132.35 Bn 1,132.35 Bn -
4 BeOne Medicines 472.73 Bn 467.94 Bn 1.35 Bn
5 Vertex Pharmaceuticals 123.52 Bn 116.27 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.74 Bn 60.99 Bn 3.31 Bn
7 Belite Bio 63.09 Bn 63.09 Bn -
8 Argenx Se 56.42 Bn 51.24 Bn 1.41 Bn
9 Revolution Medicines 37.76 Bn 37.76 Bn -
10 Protalix BioTherapeutics 191.64 Mn 180.84 Mn 29.62 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 999.00
Dec 31, 2025 -457.00
Sep 30, 2025 -1,747.00
Jun 30, 2025 3,721.00
Mar 31, 2025 11.00
Dec 31, 2024 17.00
Sep 30, 2024 1,739.00
Jun 30, 2024 -1,446.00
Mar 31, 2024 956.00